498 results
#Pathophys #Neuro #MultipleSclerosis #Topography #NEJM
#Pathophys #Neuro ... MultipleSclerosis #Topography #NEJM
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
Migraine #EBM #Neuro ... VisualAbstract #NEJM
Histologic Features and Prevalence of Nonalcoholic Steatohepatitis (NASH). NASH is a potentially progressive type of nonalcoholic
liver disease (NAFLD ... Epidemiology #NASH #NAFLD ... HCC #Prevalence #NEJM
NAFLD / NASH Progression Timeline
Healthy Liver → NAFLD/NASH → 0.25-3.2%/year → Cirrhotic NASH → 0.3-2.6%/year →
NAFLD / NASH Progression ... Healthy Liver → NAFLD ... /year → HCC • NAFLD ... Polymorphisms, Age #NAFLD
Pathogenesis of Nonalcoholic Steatohepatitis. Various factors, including inflammation, hyperinsulinemia or insulin resistance, and altered lipid homeostasis,
#GI #IM #NASH #NAFLD ... NonAlcoholicFattyLiverDisease #NEJM
Nystagmus from Wernicke’s Encephalopathy - Magnetic resonance imaging of the brain showed T2 hyperintensities involving the
Clinical #Radiology #Neuro ... MRI #Thalamus #NEJM
Cells, Molecules, and Therapies. Shown is a simplified schematic depiction of major cell types within white-matter
#Pathophys #Neuro ... DiseaseModifying #Targets #NEJM
Non-alcoholic fatty liver disease algorithm.
 
For those patients with NAFLD or liver disease of unknown aetiology,
patients with NAFLD ... calculation of a FIB4 or NAFLD ... hepatocellular carcinoma; NAFLD ... disease; NFS, NAFLD ... FattyLiver #Disease #NAFLD
Assessment of Nonalcoholic Steatohepatitis (NASH) Severity in Patients With Nonalcoholic Fatty
#Diagnosis #Pathology #NAFLD #NASH #Fibrosis #Staging
Diagnosis #Pathology #NAFLD
Elevated Liver Enzymes - Differential Diagnosis Algorithm
Severe ALT > 15x ULN
 • Viral
 • Drugs/Toxins
 •
Hemochromatosis • NAFLD ... ALT < 5x ULN • NAFLD